Spero Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $182.4M
Liabilities Breakdown FY2023
Total Liabilities: $75.5M
Asset Breakdown
Total Assets: $182.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $76.3M | 41.9% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.0K | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $106.1M | 58.1% |
Liabilities Breakdown
Total Liabilities: $75.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.4M | 1.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $74.1M | 98.2% |